SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through spike proteinEduardo A. Albornoz, Trent M. Woodruff, Nias Y. G. Peng et al.|Molecular Psychiatry|2022Cited by 178
Monoclonal Antibodies Specific for SARS-CoV-2 Spike Protein Suitable for Multiple Applications for Current Variants of ConcernMahali S. Morgan, Jody Hobson‐Peters, Kexin Yan et al.|Viruses|2022Cited by 21
A nanobody recognizes a unique conserved epitope and potently neutralizes SARS-CoV-2 omicron variantsNaphak Modhiran, Daniel Watterson, Simon Lauer et al.|iScience|2023Cited by 17
SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through spike-ACE2 receptor interactionEduardo A. Albornoz, Trent M. Woodruff, Alberto A. Amarilla et al.|bioRxiv (Cold Spring Harbor Laboratory)|2022Cited by 8
An alpaca-derived nanobody recognizes a unique conserved epitope and retains potent activity against the SARS-CoV-2 omicron variantNaphak Modhiran, Daniel Watterson, Simon Lauer et al.|bioRxiv (Cold Spring Harbor Laboratory)|2022Cited by 0